Gail Christine Gannon
Gail Christine Gannon --CEO of Ensanté, a social enterprise, 20+ years of experience helping entrepreneurs turn their great idea into market success. Recovering Investment Banker ;-), Faculty and Founding Director of Neurotech Collider Lab, UC Berkeley. She guides them through identifying target markets, finding grants and persuading investors, prototyping and refining their product or service, defining the business model, securing their first customers, and growing into new markets or partnerships. She has been instrumental in helping companies build to scale and to successful acquisition. Her most recent ventures include business coaching on behalf of the World Bank for the Republic of Georgia, helping startups establish commercial partnerships for ex-US companies. Previously, she worked with government and NGOs (e.g. PATH for the Gates Foundation), allocating health investment dollars to the most promising innovations. Gail has worked with entrepreneurs from across Asia, Europe, Africa and America on a wide range of products and services. Gail earned her master’s degree from the Harvard University T.H. Chan School of Public Health, a Patricia Roberts Harris Fellow. She also holds a Certificate of Honor in Biotechnology from University of California, Santa Cruz, an AB with honors from University of California, Berkeley and is currently on faculty in the School of Engineering. She mentors entrepreneurs through Stanford University’s SPARK and University of California-San Francisco’s Lean Launchpad, and other government and NGO innovation institutes, (Start Up Grind). Gail routinely presents at major international forums, e.g. BIO International, Horasis & Health 2.0/HIMMS. ). She is known among Corporate Venture Capitalists (Johnson & Johnson, Qualcomm). Silicon Valley “angel investors” (Astia, Band of Angels), who often seek Gail’s advice on whether and when to invest in promising startups.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.